Equity · Healthcare
CLDX
NASDAQCelldex Therapeutics (CLDX)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for CLDX to draw a line in its place.
- Market cap
- 2.3B USD
- Revenue, year to Dec 2025
- 1.5M USD
- EPS, diluted, year to Dec 2025
- −3.90 USD
- 52-week range
- 23 USD – 43 USD
- Avg volume
- 81.1K
as of Nov 6, 2026
Have Celldex Therapeutics (CLDX) insiders bought or sold shares recently?
CLDX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 2 January 2026.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 04 Dec 2025 | Jimenez Freddy A.SVP & GENERAL COUNSEL | Sell | 4,166 | 121K USD |
| 13 Nov 2025 | Wright Richard M. | Sell | 49,298 | 1.2M USD |
| Sold | 2 open-market sales | 53,464 | $1.30M |
4 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 02 Jan 2026 | Martin Samuel BatesSVP AND CFO | Option exercise | 4,817 | 50K USD |
| 15 Dec 2025 | PEPIN RONALDSR. VP & CBO | Option exercise | 19,333 | 106K USD |
| 13 Nov 2025 | Wright Richard M. | Option exercise | 49,298 | 693K USD |
| 10 Nov 2025 | Lawver Teri LSVP & Chief Commercial Officer | Award | 100,000 |
Which funds hold Celldex Therapeutics (CLDX)?
1 of the 45 institutional funds we track reported a Celldex Therapeutics position for the quarter ended 30 Sep 2026 — a combined 40.4M USD; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Added | 1,246,855 | 40.4M USD | +26.5% |
What has been filed or recorded for Celldex Therapeutics (CLDX)?
The filings we hold for Celldex Therapeutics, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.96 USD | |
| 30 Sep 2026 | Financials | Total assets | 721.5M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 649.5M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.94 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −1.18 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −3.90 USD | |
| 31 Dec 2025 | Financials | Revenue | 1.5M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −258.8M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −3.90 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −1.01 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −0.85 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −0.81 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −2.45 USD |
Celldex Therapeutics (CLDX): frequently asked questions
What is Celldex Therapeutics’ market cap?
Celldex Therapeutics is worth 2.3B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Celldex Therapeutics’ revenue?
Celldex Therapeutics reported revenue of 1.5M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Celldex Therapeutics insiders bought or sold shares recently?
No Celldex Therapeutics insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 2 Jan 2026 (SEC Form 4). See Insiders
Which funds own Celldex Therapeutics?
1 of the 45 funds we track reported a Celldex Therapeutics position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
When did Celldex Therapeutics last report earnings?
Celldex Therapeutics last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.96 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close)
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings